|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 31/65 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3348258 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18158017.6 |
| Date of filing the European patent application | 2009-03-30 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation | 2020-12-10 |
| (30) | Number | Date | Country code |
| 40398 P | 2008-03-28 | US |
| (72) |
JOHNSTON, Sean, US
|
| (73) |
Paratek Pharmaceuticals, Inc. ,
75 Park Plaza, 3rd Floor, Boston, MA 02116,
US
|
| (74) |
Aurelija ŠIDLAUSKIENĖ,
Dr. V. Šidlauskas ir partneriai, UAB, K. Būgos g. 29, LT-44326 Kaunas,
LT
|
| (54) | Per burną vartojamos ir injekuojamos tetraciklino junginių kompozicijos |
| ORAL AND INJECTABLE FORMULATIONS OF TETRACYCLINE COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-03-04 | 17 | 347.00 EUR |
| 2026-03-30 |